These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30217455)

  • 41. Evidence that tumor necrosis factor-related apoptosis-inducing ligand induction by 5-Aza-2'-deoxycytidine sensitizes human breast cancer cells to adriamycin.
    Xu J; Zhou JY; Tainsky MA; Wu GS
    Cancer Res; 2007 Feb; 67(3):1203-11. PubMed ID: 17283156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression.
    Fu XH; Zhang X; Yang H; Xu XW; Hu ZL; Yan J; Zheng XL; Wei RR; Zhang ZQ; Tang SR; Geng MY; Huang X
    Acta Pharmacol Sin; 2019 May; 40(5):677-688. PubMed ID: 30224636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells.
    Yang L; Liang Q; Shen K; Ma L; An N; Deng W; Fei Z; Liu J
    Biomed Pharmacother; 2015 Apr; 71():70-8. PubMed ID: 25960218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells.
    Dawood M; Elbadawi M; Böckers M; Bringmann G; Efferth T
    Biomed Pharmacother; 2020 Sep; 129():110454. PubMed ID: 32768947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
    Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
    Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
    [No Abstract]   [Full Text] [Related]  

  • 46. Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells.
    Zhou T; Duan J; Wang Y; Chen X; Zhou G; Wang R; Fu L; Xu F
    Tumour Biol; 2012 Oct; 33(5):1299-306. PubMed ID: 22549660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brazilin induces apoptosis and G2/M arrest via inactivation of histone deacetylase in multiple myeloma U266 cells.
    Kim B; Kim SH; Jeong SJ; Sohn EJ; Jung JH; Lee MH; Kim SH
    J Agric Food Chem; 2012 Oct; 60(39):9882-9. PubMed ID: 22967175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxia suppresses chemotherapeutic drug-induced p53 Serine 46 phosphorylation by triggering HIPK2 degradation.
    Moehlenbrink J; Bitomsky N; Hofmann TG
    Cancer Lett; 2010 Jun; 292(1):119-24. PubMed ID: 20018442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Roles of p53 in adriamycin-induced cell death and in acquisition of adriamycin resistance in adult T-cell leukemia (ATL) cells].
    Cho Y
    Hokkaido Igaku Zasshi; 1999 May; 74(3):239-48. PubMed ID: 10422567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The synergistic effect of 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside combined with Adriamycin on MCF-7 breast cancer cells.
    Shen J; Zhang Y; Shen H; Pan H; Xu L; Yuan L; Ding Z
    Drug Des Devel Ther; 2018; 12():4083-4094. PubMed ID: 30555223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The combination of recombinant rAd-p53 and adriamycin for management of primary drug resistance in chemotherapy of lung squamous cell cancer].
    Du CH; Wu Z; Xu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):622-4. PubMed ID: 17129471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The selective HDAC6 inhibitor Nexturastat A induces apoptosis, overcomes drug resistance and inhibits tumor growth in multiple myeloma.
    Sun X; Xie Y; Sun X; Yao Y; Li H; Li Z; Yao R; Xu K
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30782785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physalin B induces cell cycle arrest and triggers apoptosis in breast cancer cells through modulating p53-dependent apoptotic pathway.
    Wang A; Wang S; Zhou F; Li P; Wang Y; Gan L; Lin L
    Biomed Pharmacother; 2018 May; 101():334-341. PubMed ID: 29499407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter.
    Qiu JG; Zhang YJ; Li Y; Zhao JM; Zhang WJ; Jiang QW; Mei XL; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Shi Z
    Oncotarget; 2015 Jun; 6(17):15494-509. PubMed ID: 25915534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis.
    Ryu HW; Shin DH; Lee DH; Choi J; Han G; Lee KY; Kwon SH
    Cancer Lett; 2017 Apr; 391():162-171. PubMed ID: 28153791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Reversal of resistance to adriamycin in human breast cancer cell line MCF-7/ADM by silencing AEG-1 gene and its mechanism].
    Yuan L; Shi RR; Rao SM; Song JL; Cui MC
    Sheng Li Xue Bao; 2014 Oct; 66(5):625-30. PubMed ID: 25332010
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
    Xu P; Jiang YF; Wang JH
    Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells.
    Pai JT; Hsu CY; Hua KT; Yu SY; Huang CY; Chen CN; Liao CH; Weng MS
    Molecules; 2015 May; 20(5):8000-19. PubMed ID: 25946558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.